 | • レポートコード：QAF27719 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のヒト血液凝固因子VIII市場について種類別（遺伝子組換え型第VIII因子、血漿由来第VIII因子）、用途別（血友病A、自然発症/外傷、外科、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒト血液凝固因子VIII市場の概要 ・世界の主要地域別ヒト血液凝固因子VIII市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のヒト血液凝固因子VIII市場規模2016-2021：種類別（遺伝子組換え型第VIII因子、血漿由来第VIII因子） ・世界のヒト血液凝固因子VIII市場予測2012-2027：種類別（遺伝子組換え型第VIII因子、血漿由来第VIII因子） ・世界のヒト血液凝固因子VIII市場規模2016-2021：用途別（血友病A、自然発症/外傷、外科、その他） ・世界のヒト血液凝固因子VIII市場予測2012-2027：用途別（血友病A、自然発症/外傷、外科、その他） ・ヒト血液凝固因子VIIIのアメリカ市場規模と予測2016-2021 ・ヒト血液凝固因子VIIIのヨーロッパ市場規模と予測2016-2021 ・ヒト血液凝固因子VIIIの中国市場規模と予測2016-2021 ・ヒト血液凝固因子VIIIの日本市場規模と予測2016-2021 ・ヒト血液凝固因子VIIIの東南アジア市場規模と予測2016-2021 ・ヒト血液凝固因子VIIIのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Shire (Baxter)、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS） ・ヒト血液凝固因子VIIIの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒト血液凝固因子VIIIの市場動向・機会・課題 ・調査の結論 |
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.
The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.
Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.
Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.
Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.
Market Analysis and Insights: Global Human Coagulation Factor VIII Market
The global Human Coagulation Factor VIII market was valued at US$ 8412.3 in 2020 and will reach US$ 10040 million by the end of 2027, growing at a CAGR of 3.0% during 2022-2027.
Global Human Coagulation Factor VIII Scope and Market Size
The global Human Coagulation Factor VIII market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor VIII market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Other
The Human Coagulation Factor VIII market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Coagulation Factor VIII market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
1 Human Coagulation Factor VIII Market Overview
1.1 Human Coagulation Factor VIII Product Scope
1.2 Human Coagulation Factor VIII Segment by Type
1.2.1 Global Human Coagulation Factor VIII Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Segment by Application
1.3.1 Global Human Coagulation Factor VIII Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Human Coagulation Factor VIII Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Coagulation Factor VIII Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Coagulation Factor VIII Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Coagulation Factor VIII Price Trends (2016-2027)
2 Human Coagulation Factor VIII Estimates and Forecasts by Region
2.1 Global Human Coagulation Factor VIII Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Coagulation Factor VIII Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
2.3 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.2 Europe Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.3 China Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.4 Japan Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.6 India Human Coagulation Factor VIII Estimates and Projections (2016-2027)
3 Global Human Coagulation Factor VIII Competition Landscape by Players
3.1 Global Top Human Coagulation Factor VIII Players by Sales (2016-2021)
3.2 Global Top Human Coagulation Factor VIII Players by Revenue (2016-2021)
3.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2020)
3.4 Global Human Coagulation Factor VIII Average Price by Company (2016-2021)
3.5 Manufacturers Human Coagulation Factor VIII Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Coagulation Factor VIII Market Size by Type
4.1 Global Human Coagulation Factor VIII Historic Market Review by Type (2016-2021)
4.1.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Coagulation Factor VIII Price by Type (2016-2021)
4.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2022-2027)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Coagulation Factor VIII Price Forecast by Type (2022-2027)
5 Global Human Coagulation Factor VIII Market Size by Application
5.1 Global Human Coagulation Factor VIII Historic Market Review by Application (2016-2021)
5.1.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
5.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Coagulation Factor VIII Price by Application (2016-2021)
5.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2022-2027)
5.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2022-2027)
6 North America Human Coagulation Factor VIII Market Facts & Figures
6.1 North America Human Coagulation Factor VIII Sales by Company
6.1.1 North America Human Coagulation Factor VIII Sales by Company (2016-2021)
6.1.2 North America Human Coagulation Factor VIII Revenue by Company (2016-2021)
6.2 North America Human Coagulation Factor VIII Sales Breakdown by Type
6.2.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
6.3 North America Human Coagulation Factor VIII Sales Breakdown by Application
6.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Coagulation Factor VIII Sales Breakdown by Application (2022-2027)
7 Europe Human Coagulation Factor VIII Market Facts & Figures
7.1 Europe Human Coagulation Factor VIII Sales by Company
7.1.1 Europe Human Coagulation Factor VIII Sales by Company (2016-2021)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Company (2016-2021)
7.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type
7.2.1 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
7.3 Europe Human Coagulation Factor VIII Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Human Coagulation Factor VIII Market Facts & Figures
8.1 China Human Coagulation Factor VIII Sales by Company
8.1.1 China Human Coagulation Factor VIII Sales by Company (2016-2021)
8.1.2 China Human Coagulation Factor VIII Revenue by Company (2016-2021)
8.2 China Human Coagulation Factor VIII Sales Breakdown by Type
8.2.1 China Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
8.2.2 China Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
8.3 China Human Coagulation Factor VIII Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Human Coagulation Factor VIII Market Facts & Figures
9.1 Japan Human Coagulation Factor VIII Sales by Company
9.1.1 Japan Human Coagulation Factor VIII Sales by Company (2016-2021)
9.1.2 Japan Human Coagulation Factor VIII Revenue by Company (2016-2021)
9.2 Japan Human Coagulation Factor VIII Sales Breakdown by Type
9.2.1 Japan Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
9.3 Japan Human Coagulation Factor VIII Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Coagulation Factor VIII Market Facts & Figures
10.1 Southeast Asia Human Coagulation Factor VIII Sales by Company
10.1.1 Southeast Asia Human Coagulation Factor VIII Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Coagulation Factor VIII Revenue by Company (2016-2021)
10.2 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type
10.2.1 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Human Coagulation Factor VIII Market Facts & Figures
11.1 India Human Coagulation Factor VIII Sales by Company
11.1.1 India Human Coagulation Factor VIII Sales by Company (2016-2021)
11.1.2 India Human Coagulation Factor VIII Revenue by Company (2016-2021)
11.2 India Human Coagulation Factor VIII Sales Breakdown by Type
11.2.1 India Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
11.2.2 India Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
11.3 India Human Coagulation Factor VIII Sales Breakdown by Application
11.3.1 India Human Coagulation Factor VIII Sales Breakdown by Application (2016-2021)
11.3.2 India Human Coagulation Factor VIII Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Coagulation Factor VIII Business
12.1 Shire (Baxter)
12.1.1 Shire (Baxter) Corporation Information
12.1.2 Shire (Baxter) Business Overview
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
12.1.5 Shire (Baxter) Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Human Coagulation Factor VIII Products Offered
12.2.5 Bayer Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Human Coagulation Factor VIII Products Offered
12.3.5 CSL Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Human Coagulation Factor VIII Products Offered
12.4.5 Pfizer Recent Development
12.5 Grifols
12.5.1 Grifols Corporation Information
12.5.2 Grifols Business Overview
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Grifols Human Coagulation Factor VIII Products Offered
12.5.5 Grifols Recent Development
12.6 Biogen
12.6.1 Biogen Corporation Information
12.6.2 Biogen Business Overview
12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Biogen Human Coagulation Factor VIII Products Offered
12.6.5 Biogen Recent Development
12.7 Octapharma
12.7.1 Octapharma Corporation Information
12.7.2 Octapharma Business Overview
12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Octapharma Human Coagulation Factor VIII Products Offered
12.7.5 Octapharma Recent Development
12.8 NovoNordisk
12.8.1 NovoNordisk Corporation Information
12.8.2 NovoNordisk Business Overview
12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
12.8.5 NovoNordisk Recent Development
12.9 Greencross
12.9.1 Greencross Corporation Information
12.9.2 Greencross Business Overview
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Greencross Human Coagulation Factor VIII Products Offered
12.9.5 Greencross Recent Development
12.10 Kedrion
12.10.1 Kedrion Corporation Information
12.10.2 Kedrion Business Overview
12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kedrion Human Coagulation Factor VIII Products Offered
12.10.5 Kedrion Recent Development
12.11 BPL
12.11.1 BPL Corporation Information
12.11.2 BPL Business Overview
12.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.11.4 BPL Human Coagulation Factor VIII Products Offered
12.11.5 BPL Recent Development
12.12 Hualan Bio
12.12.1 Hualan Bio Corporation Information
12.12.2 Hualan Bio Business Overview
12.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
12.12.5 Hualan Bio Recent Development
12.13 RAAS
12.13.1 RAAS Corporation Information
12.13.2 RAAS Business Overview
12.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.13.4 RAAS Human Coagulation Factor VIII Products Offered
12.13.5 RAAS Recent Development
13 Human Coagulation Factor VIII Manufacturing Cost Analysis
13.1 Human Coagulation Factor VIII Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
13.4 Human Coagulation Factor VIII Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Coagulation Factor VIII Distributors List
14.3 Human Coagulation Factor VIII Customers
15 Market Dynamics
15.1 Human Coagulation Factor VIII Market Trends
15.2 Human Coagulation Factor VIII Drivers
15.3 Human Coagulation Factor VIII Market Challenges
15.4 Human Coagulation Factor VIII Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Coagulation Factor VIII Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Coagulation Factor VIII Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Coagulation Factor VIII Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Coagulation Factor VIII Sales (Kg) by Region (2016-2021)
Table 5. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Table 6. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Coagulation Factor VIII Revenue Share by Region (2016-2021)
Table 8. Global Human Coagulation Factor VIII Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Coagulation Factor VIII Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Coagulation Factor VIII Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Coagulation Factor VIII Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Human Coagulation Factor VIII Sales Share by Company (2016-2021)
Table 14. Global Human Coagulation Factor VIII Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Coagulation Factor VIII Revenue Share by Company (2016-2021)
Table 16. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VIII as of 2020)
Table 17. Global Human Coagulation Factor VIII Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Human Coagulation Factor VIII Manufacturing Sites and Area Served
Table 19. Manufacturers Human Coagulation Factor VIII Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Coagulation Factor VIII Sales (Kg) by Type (2016-2021)
Table 22. Global Human Coagulation Factor VIII Sales Share by Type (2016-2021)
Table 23. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Coagulation Factor VIII Price (USD/Kg) by Type (2016-2021)
Table 25. Global Human Coagulation Factor VIII Sales Share by Type (2022-2027)
Table 26. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Coagulation Factor VIII Revenue Share by Type (2022-2027)
Table 28. Global Human Coagulation Factor VIII Price (USD/Kg) by Type (2022-2027)
Table 29. Global Human Coagulation Factor VIII Sales (Kg) by Application (2016-2021)
Table 30. Global Human Coagulation Factor VIII Sales Share by Application (2016-2021)
Table 31. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Coagulation Factor VIII Price (USD/Kg) by Application (2016-2021)
Table 33. Global Human Coagulation Factor VIII Sales (Kg) by Application (2022-2027)
Table 34. Global Human Coagulation Factor VIII Sales Share by Application (2022-2027)
Table 35. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Coagulation Factor VIII Revenue Share by Application (2022-2027)
Table 37. Global Human Coagulation Factor VIII Price (USD/Kg) by Application (2022-2027)
Table 38. North America Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 39. North America Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 40. North America Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 42. North America Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 43. North America Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 44. North America Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 45. North America Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 46. North America Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 47. North America Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 48. North America Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 49. North America Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 50. Europe Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 51. Europe Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 52. Europe Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 55. Europe Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 56. Europe Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 57. Europe Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 58. Europe Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 59. Europe Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 60. Europe Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 61. Europe Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 62. China Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 63. China Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 64. China Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 66. China Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 67. China Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 68. China Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 69. China Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 70. China Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 71. China Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 72. China Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 73. China Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 74. Japan Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 75. Japan Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 76. Japan Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 79. Japan Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 80. Japan Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 81. Japan Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 82. Japan Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 83. Japan Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 84. Japan Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 85. Japan Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 98. India Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 99. India Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 100. India Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 102. India Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 103. India Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 104. India Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 105. India Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 106. India Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 107. India Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 108. India Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 109. India Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 110. Shire (Baxter) Corporation Information
Table 111. Shire (Baxter) Description and Business Overview
Table 112. Shire (Baxter) Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Shire (Baxter) Human Coagulation Factor VIII Product
Table 114. Shire (Baxter) Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Bayer Human Coagulation Factor VIII Product
Table 119. Bayer Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. CSL Human Coagulation Factor VIII Product
Table 124. CSL Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Pfizer Human Coagulation Factor VIII Product
Table 129. Pfizer Recent Development
Table 130. Grifols Corporation Information
Table 131. Grifols Description and Business Overview
Table 132. Grifols Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Grifols Human Coagulation Factor VIII Product
Table 134. Grifols Recent Development
Table 135. Biogen Corporation Information
Table 136. Biogen Description and Business Overview
Table 137. Biogen Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Biogen Human Coagulation Factor VIII Product
Table 139. Biogen Recent Development
Table 140. Octapharma Corporation Information
Table 141. Octapharma Description and Business Overview
Table 142. Octapharma Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Octapharma Human Coagulation Factor VIII Product
Table 144. Octapharma Recent Development
Table 145. NovoNordisk Corporation Information
Table 146. NovoNordisk Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. NovoNordisk Description and Business Overview
Table 148. NovoNordisk Human Coagulation Factor VIII Product
Table 149. NovoNordisk Recent Development
Table 150. Greencross Corporation Information
Table 151. Greencross Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Greencross Description and Business Overview
Table 153. Greencross Human Coagulation Factor VIII Product
Table 154. Greencross Recent Development
Table 155. Kedrion Corporation Information
Table 156. Kedrion Description and Business Overview
Table 157. Kedrion Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Kedrion Human Coagulation Factor VIII Product
Table 159. Kedrion Recent Development
Table 160. BPL Corporation Information
Table 161. BPL Description and Business Overview
Table 162. BPL Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. BPL Human Coagulation Factor VIII Product
Table 164. BPL Recent Development
Table 165. Hualan Bio Corporation Information
Table 166. Hualan Bio Description and Business Overview
Table 167. Hualan Bio Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Hualan Bio Human Coagulation Factor VIII Product
Table 169. Hualan Bio Recent Development
Table 170. RAAS Corporation Information
Table 171. RAAS Description and Business Overview
Table 172. RAAS Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. RAAS Human Coagulation Factor VIII Product
Table 174. RAAS Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Human Coagulation Factor VIII Distributors List
Table 178. Human Coagulation Factor VIII Customers List
Table 179. Human Coagulation Factor VIII Market Trends
Table 180. Human Coagulation Factor VIII Market Drivers
Table 181. Human Coagulation Factor VIII Market Challenges
Table 182. Human Coagulation Factor VIII Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2021 & 2027
Figure 6. Hemophilia A Examples
Figure 7. Spontanous / Trauma Examples
Figure 8. Surgical Examples
Figure 9. Other Examples
Figure 10. Global Human Coagulation Factor VIII Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Coagulation Factor VIII Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Human Coagulation Factor VIII Sales (Kg) Growth Rate (2016-2027)
Figure 13. Global Human Coagulation Factor VIII Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Human Coagulation Factor VIII Sales (Kg) Growth Rate (2016-2027)
Figure 18. Europe Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Human Coagulation Factor VIII Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Human Coagulation Factor VIII Players Market Share by Revenue in Human Coagulation Factor VIII: 2016 & 2020
Figure 29. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Human Coagulation Factor VIII Revenue Share by Type (2016-2021)
Figure 31. Global Human Coagulation Factor VIII Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Human Coagulation Factor VIII Revenue Share by Application (2016-2021)
Figure 33. Global Human Coagulation Factor VIII Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 35. North America Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 36. Europe Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 37. Europe Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 38. China Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 39. China Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 40. Japan Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 41. Japan Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 42. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 43. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 44. India Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 45. India Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Human Coagulation Factor VIII
Figure 48. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 49. Human Coagulation Factor VIII Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
ヒト血液凝固因子VIIのグローバル市場2021 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…- 組換え第VIII因子のグローバル市場調査 2019年 The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspecti…
- 組換え第VIII因子のグローバル市場調査 2019年 The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspecti…
- ヒト凝固因子Ⅷのグローバル市場調査 2019年 The global Human Coagulation Factor Ⅷ market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Coagulation Factor Ⅷ volume and value at global level, regional level and company level. From a global per…
- カーバムファクターVIIIのグローバル市場調査 2019年 The global Car Bum Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Car Bum Factor VIII volume and value at global level, regional level and company level. From a global perspective, this…